In 2019 the COVID-19 pandemic first began, affecting the whole world and killing millions of people. In 2020 COVID-19 arrived in Africa threatening to overwhelm the local health systems and causing problems across communities. COVID-19 symptoms include a fever, cough, tiredness, loss of taste or smell and severe cases filled hospitals and clinics.
In 2021 different COVID-19 Vaccines were introduced and approved for use in people aged 18 and above. These vaccines include Pfizer, Moderna, Johnson & Johnson, and AstraZeneca. All vaccines must be stored within the recommended temperature range of +2°C to +8°C at all times. Maintaining the cold chain is important to ensure that effective and potent vaccines are administered to patients
Aptech Africa in partnership with Dulas brings you Vaccine fridges that are both DC and AC to safely keep Covid-19 vaccines in Africa. Dulas solar vaccine refrigerator systems have WHO PQS accreditation and we are confident that you can rely on our products to work 365 days a year in the field and on the road. The vaccine fridges offer the perfect balance of array size and autonomy to deliver exceptional reliability whatever the weather. Dulas solar refrigerators are fully GAVI CCEOP compliant with the highest level of Grade A Freeze Protection and a +5C to +43C extended temperature operating range
These vaccines reduce risk of infection.
Once you receive your first shot, your body begins producing antibodies to the coronavirus. These antibodies help your immune system fight the virus if you happen to be exposed, so it reduces your chance of getting the disease. There are four vaccines available for use, and they are all more than 70% effective in preventing infection.
It’s true that you can still become infected after being vaccinated, but once more of the population is vaccinated, those chances are further reduced thanks to something called herd immunity. So, getting vaccinated not only reduces your chance of being infected, it also contributes to community protection, reducing the likelihood of virus transmission.
The vaccine can help unborn babies or newborns.
Studies have found that expectant mothers who receive the COVID-19 vaccine create antibodies to the virus and pass those to their unborn baby through the placenta. Mothers were also shown to pass antibodies to their newborns through breast milk. This suggests those newborns have some immunity to the virus, which is especially important as young children cannot get the vaccine.